A Randomized, Double-Blind, Phase 3 Comparison of Platinum‑Based Therapy with TSR‑042 and Niraparib Versus Standard of Care Platinum‑Based Therapy as First‑line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer

Required
Required
Required